5 myths about PrEP (and the facts you need to know) debunks some common misperceptions about going on PrEP to prevent HIV. Get informed and take control of your health.
A new research study to help increase access to PrEP has been launched in Toronto by St. Michael's Hospital - a leader in HIV treatment and research, funded in part by the Canadian HIV Trials. If you're considering PrEP, and you're gay, bisexual or trans, you are invited to participate. The study includes an optional survey, a 20 minute video and information about PrEP for you to take to your family doctor.
New guidelines for prescribing PrEP and nPEP to prevent HIV infection have been laid out for Canadian doctors and other primary care practitioners by the Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network. The guideline has been published in CMAJ. The guideline outlines how and when to prescribe PrEP and nPEP and will help increase awareness and access to research-based HIV prevention options, and decrease the incidence of HIV infection over time.
PrEP terminology can sometimes get complicated and there's lots of confusion out there! This post lists common terms related to PrEP. We'll define terms like 'Serodiscordant' and 'U=U,' and provide explanations for 'Trillium' and 'Generic Truvada' so you'll be better informed to take control of your health.